XPONDRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Aug 2022)
What this means for you
This application is over — abandoned 01 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88237374
- Mark type
- Stylized text
- Filed
- 20 Dec 2018
- Published for opposition
- 30 Apr 2019
- Abandoned
- 01 Aug 2022
- Attorney of record
- Stephanie K. Wade
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- CytomX Therapeutics, Inc., South San Francisco, CA, US
- CytomX Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 01 Aug 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Aug 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2021 — SOU EXTENSION 5 GRANTED
- 22 Nov 2021 — SOU EXTENSION 5 FILED
- 22 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 05 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2021 — SOU EXTENSION 4 GRANTED
- 03 Jun 2021 — SOU EXTENSION 4 FILED
- 03 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 01 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2020 — SOU EXTENSION 3 GRANTED
- 11 Dec 2020 — SOU EXTENSION 3 FILED
- 31 Dec 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Dec 2020 — SOU TEAS EXTENSION RECEIVED